NMDA型グルタミン酸受容体の活性化により,AKT1-TBX3-Nav1.5軸をターゲットにすることで,血動不律が促進される
Yuxian He1, Han Zhang2, Qinggang Zhang1
1Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, China.
Acta physiologica (Oxford, England)
|August 22, 2025
まとめ
N-メチル-D-アスパルテート受容体 (NMDAR) の活性化は,イオンチャネル機能を破壊することによって,心臓発作誘発性不律に寄与する. NMDARを阻害することで,不動脈不律の新たな治療法が提供される可能性があります.
科学分野:
- 心血管研究
- 神経科学
- 分子生物学
背景:
- 心筋梗塞 (MI) は電気再構成と心室不律 (VAs) を引き起こします.
- この過程におけるN-メチル-D-アスパルテート受容体 (NMDAR) の役割は完全に理解されていません.
研究 の 目的:
- NMDARの調節不全がMIによって引き起こされる電気再構築の役割を調査する.
- NMDARがイオンチャネル発現と機能に影響を与えるメカニズムを解明する.
主な方法:
- 免疫光とウェスタン・ブロッティングを用いたヒトとマウスの心臓組織の分析.
- MI後のマウスの心電図モニタリング
- パッチ・クランプの記録と 遺伝子発現の分析で 電気的改造を評価する
- 機械学的研究のための生物情報分析,転移,および変異.
主要な成果:
- NMDARは心臓発作患者およびマウスで上位調節され,VAsと相関しています.
- NMDARの抑制により,VAが減少し,イオンチャネル発現が回復した (Nav1. 5,Kv11. 1,Kv4. 2,Kv7. 1,Kir2. 1,Cav1. 2).
- NMDARの活性化は,AKT1によって調節されるNav1.5を調節するTBX3を調節します.
結論:
- NMDARの活性化は,AKT1-TBX3-Nav1.5経路を通じてMI誘発のVAsを駆動する.
- NMDARを標的とした治療は,不全性心律不全の治療戦略の可能性がある.
関連する概念動画
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.6K
Enzyme-linked Receptors
79.9K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
79.9K
Antiepileptic Drugs: Glutamate Antagonists
512
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
512
Mechanism of Cardiac Arrhythmias
1.1K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.1K
G-Protein Gated Ion Channels
4.8K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.8K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.2K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.2K


